Arja Kaipainen
Rockefeller University(US)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Prostate Cancer Treatment and Research, Lymphatic System and Diseases, Protein Degradation and Inhibitors, Cancer, Lipids, and Metabolism
Most-Cited Works
- → A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.(1996)1,679 cited
- → Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.(1995)1,441 cited
- → Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice(1997)1,291 cited
- → Vascular endothelial growth factor B, a novel growth factor for endothelial cells.(1996)822 cited
- → Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling(2017)740 cited
- → VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development(1996)692 cited
- → Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.(1994)692 cited
- → Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer(2019)446 cited
- → PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis(2002)350 cited
- Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.(1998)